These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15358989)
1. The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study. Conley RR; Kelly DL; Beason-Held LL; Holcomb HH; Richardson CM J Psychopharmacol; 2004 Sep; 18(3):429-31. PubMed ID: 15358989 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726 [TBL] [Abstract][Full Text] [Related]
6. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Kelly DL; Conley RR; Richardson CM; Tamminga CA; Carpenter WT Ann Clin Psychiatry; 2003; 15(3-4):181-6. PubMed ID: 14971863 [TBL] [Abstract][Full Text] [Related]
7. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Naber D; Riedel M; Klimke A; Vorbach EU; Lambert M; Kühn KU; Bender S; Bandelow B; Lemmer W; Moritz S; Dittmann RW Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429 [TBL] [Abstract][Full Text] [Related]
8. Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents. Kumra S; Jacobsen LK; Lenane M; Karp BI; Frazier JA; Smith AK; Bedwell J; Lee P; Malanga CJ; Hamburger S; Rapoport JL J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):377-85. PubMed ID: 9549958 [TBL] [Abstract][Full Text] [Related]
9. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133 [TBL] [Abstract][Full Text] [Related]
10. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
11. LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia. Tislerova B; Brunovsky M; Horacek J; Novak T; Kopecek M; Mohr P; Krajca V Neuropsychobiology; 2008; 58(1):1-10. PubMed ID: 18781085 [TBL] [Abstract][Full Text] [Related]
12. Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study. Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; DeThomas C; Cullen K; Regan J; Kane JM J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):307-16. PubMed ID: 18759640 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature. Kluge M; Schacht A; Himmerich H; Rummel-Kluge C; Wehmeier PM; Dalal M; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T; Schuld A Schizophr Res; 2014 Jan; 152(1):255-60. PubMed ID: 24315135 [TBL] [Abstract][Full Text] [Related]
14. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia. Pickar D; Bartko JJ Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272 [TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Conley RR; Tamminga CA; Kelly DL; Richardson CM Biol Psychiatry; 1999 Jul; 46(1):73-7. PubMed ID: 10394475 [TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835 [TBL] [Abstract][Full Text] [Related]
18. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Kapur S; Zipursky RB; Remington G Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565 [TBL] [Abstract][Full Text] [Related]